A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy

Filip K Knop; Shweta Urva; Mallikarjuna Rettiganti; Charles T Benson; William C Roell; Kieren J Mather; Axel Haupt; Edward John Pratt

doi:10.1111/dom.15875

A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy

Filip K Knop, Shweta Urva, Mallikarjuna Rettiganti, Charles T Benson, William C Roell, Kieren J Mather, Axel Haupt, Edward John Pratt

23 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	26
Udgave nummer	11
Sider (fra-til)	5474-5478
Antal sider	5
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.15875
Status	Udgivet - nov. 2024

Adgang til dokumentet

10.1111/dom.15875

Andre filer og links

Link to publication in Scopus

Citationsformater

Knop, F. K., Urva, S., Rettiganti, M., Benson, C. T., Roell, W. C., Mather, K. J., Haupt, A., & Pratt, E. J. (2024). A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy. Diabetes, Obesity and Metabolism, 26(11), 5474-5478. https://doi.org/10.1111/dom.15875

A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy. / Knop, Filip K; Urva, Shweta; Rettiganti, Mallikarjuna et al.
I: Diabetes, Obesity and Metabolism, Bind 26, Nr. 11, 11.2024, s. 5474-5478.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{f34b5f503f284d458292556bbd073f02,

title = "A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy",

keywords = "Diabetes Mellitus, Type 2/drug therapy, Female, Gastric Inhibitory Polypeptide/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/therapeutic use, Male, Middle Aged, Receptors, Gastrointestinal Hormone/agonists, clinical trial, GLP-1, GIP, antidiabetic drug, antiobesity drug, incretin therapy",

author = "Knop, {Filip K} and Shweta Urva and Mallikarjuna Rettiganti and Benson, {Charles T} and Roell, {William C} and Mather, {Kieren J} and Axel Haupt and Pratt, {Edward John}",

year = "2024",

month = nov,

doi = "10.1111/dom.15875",

language = "English",

volume = "26",

pages = "5474--5478",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

TY - JOUR

T1 - A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy

AU - Knop, Filip K

AU - Urva, Shweta

AU - Rettiganti, Mallikarjuna

AU - Benson, Charles T

AU - Roell, William C

AU - Mather, Kieren J

AU - Haupt, Axel

AU - Pratt, Edward John

PY - 2024/11

Y1 - 2024/11

KW - Diabetes Mellitus, Type 2/drug therapy

KW - Female

KW - Gastric Inhibitory Polypeptide/therapeutic use

KW - Glucagon-Like Peptide-1 Receptor/agonists

KW - Humans

KW - Hypoglycemic Agents/therapeutic use

KW - Male

KW - Middle Aged

KW - Receptors, Gastrointestinal Hormone/agonists

KW - clinical trial

KW - GLP-1

KW - GIP

KW - antidiabetic drug

KW - antiobesity drug

KW - incretin therapy

UR - http://www.scopus.com/inward/record.url?scp=85202044883&partnerID=8YFLogxK

U2 - 10.1111/dom.15875

DO - 10.1111/dom.15875

M3 - Journal article

C2 - 39188238

SN - 1462-8902

VL - 26

SP - 5474

EP - 5478

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 11

ER -